Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMAAU
10951
Drugs Made In America Acquisition Corp Units
DMAAU
| $145K | ﹤0.01% |
14,026
-1,727
| -11% | -$17.7K |
|
10952
PUT
Vir Biotechnology
VIR
$1.56B
| $145K | ﹤0.01% |
28,700
-2,200
| -7% | -$11.8K |
|
|
FOCL
10953
CALL
EDAP TMS S.A.
FOCL
$178M
| $144K | ﹤0.01% |
87,900
+51,100
| +139% | +$92K |
|
10954
PUT
ReNew
RNW
$2.48B
| $144K | ﹤0.01% |
20,800
+6,500
| +45% | +$42.4K |
|
10955
CALL
Amprius Technologies
AMPX
$1.83B
| $144K | ﹤0.01% |
34,100
-27,000
| -44% | -$75.9K |
|
10956
YieldMax AAPL Option Income Strategy ETF
APLY
$117M
| $143K | ﹤0.01% |
11,128
-10,919
| -50% | -$145K |
|
10957
PUT
Lufax Holding
LU
$1.3B
| $143K | ﹤0.01% |
51,300
-108,400
| -68% | -$306K |
|
|
NSLR
10958
CALL
Neostellar Capital Corp
NSLR
$278M
| $143K | ﹤0.01% |
17,400
-10,300
| -37% | -$61.3K |
|
10959
CALL
Rocket Pharmaceuticals
RCKT
$381M
| $143K | ﹤0.01% |
58,300
+3,200
| +6% | +$16.2K |
|
|
TE
10960
T1 Energy
TE
$1.51B
| $143K | ﹤0.01% |
115,971
+72,720
| +168% | +$88.6K |
|
10961
CALL
Aegon
AEG
$14B
| $143K | ﹤0.01% |
19,700
+14,700
| +294% | +$98.3K |
|
10962
PUT
Gold Royalty Corp
GROY
$727M
| $142K | ﹤0.01% |
64,300
+25,700
| +67% | +$45.1K |
|
10963
CALL
Ocean Power Technologies
OPTT
$55.9M
| $142K | ﹤0.01% |
298,900
-53,100
| -15% | -$25.2K |
|
10964
OFS Capital
OFS
$48.1M
| $142K | ﹤0.01% |
+16,776
| New | +$144K |
|
10965
PUT
Lyell Immunopharma
LYEL
$342M
| $141K | ﹤0.01% |
15,990
+15,690
| +5,230% | +$143K |
|
10966
PUT
SurgePays
SURG
$7.08M
| $141K | ﹤0.01% |
45,300
+41,300
| +1,033% | +$114K |
|
|
PHLT
10967
DELISTED
Performant Healthcare Inc
PHLT
| $141K | ﹤0.01% |
35,301
-132,396
| -79% | -$375K |
|
10968
PUT
Suzano
SUZ
$9.99B
| $141K | ﹤0.01% |
15,000
-400
| -3% | -$3.67K |
|
10969
Evotec
EVO
$697M
| $141K | ﹤0.01% |
+33,574
| New | +$132K |
|
|
INZY
10970
DELISTED
Inozyme Pharma
INZY
| $141K | ﹤0.01% |
35,166
-144,849
| -80% | -$359K |
|
|
LEO
10971
BNY Mellon Strategic Municipals
LEO
$390M
| $141K | ﹤0.01% |
+23,753
| New | +$139K |
|
|
VSTD
10972
DELISTED
Vestand Inc
VSTD
| $141K | ﹤0.01% |
+58,148
| New | +$201K |
|
|
WLAC
10973
DELISTED
Willow Lane Acquisition Corp
WLAC
| $140K | ﹤0.01% |
13,734
-1,065
| -7% | -$10.8K |
|
10974
CALL
JELD-WEN Holding
JELD
$167M
| $140K | ﹤0.01% |
35,800
-20,400
| -36% | -$90.9K |
|
|
GLQ
10975
Clough Global Equity Fund
GLQ
$156M
| $140K | ﹤0.01% |
+19,686
| New | +$128K |
|
Similar funds
Citadel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Citadel Advisors held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Citadel Advisors withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Walmart Inc worth $401M.
- Citadel Advisors's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Citadel Advisors added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Citadel Advisors's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Citadel Advisors fully exited Kroger in Q2 2025, selling an estimated $558M.
- Citadel Advisors's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Citadel Advisors opened 1,459 new positions and closed 3,524 in Q2 2025.
- Citadel Advisors's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.